Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter U Fischer

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
The American Journal of Tropical Medicine and Hygiene|October 9, 2008
Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needsDominique Kyelem, Gautam Biswas, Moses J Bockarie, et al.
Plos Neglected Tropical Diseases|May 19, 2023
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasisNicholas O Opoku, Felix Doe, Bettina Dubben, et al.
Plos Neglected Tropical Diseases|December 12, 2022
Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in AfricaWilma A Stolk, Luc E Coffeng, Fatorma K Bolay, et al.
Plos Genetics|January 7, 2017
Genomes of Fasciola hepatica from the Americas Reveal Colonization with Neorickettsia Endobacteria Related to the Agents of Potomac Horse and Human Sennetsu FeversSamantha N McNulty, Jose F Tort, Gabriel Rinaldi, et al.
Plos Neglected Tropical Diseases|January 9, 2016
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulusAllison Golden, Eric J Stevens, Lindsay Yokobe, et al.
Plos Neglected Tropical Diseases|March 9, 2019
Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in CameroonSamuel Wanji, Mathias Eyong Esum, Abdel Jelil Njouendou, et al.
Plos Medicine|June 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized studyGary J Weil, Joshua Bogus, Michael Christian, et al.
Plos Neglected Tropical Diseases|March 3, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasisAlison Krentel, Nandha Basker, Madsen Beau de Rochars, et al.
Plos Neglected Tropical Diseases|January 25, 2012
A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasisKatherine Gass, Madsen V E Beau de Rochars, Daniel Boakye, et al.
Plos Neglected Tropical Diseases|December 17, 2013
Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluationBrian K Chu, Michael Deming, Nana-Kwadwo Biritwum, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
The American Journal of Tropical Medicine and Hygiene|October 9, 2008
Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needsDominique Kyelem, Gautam Biswas, Moses J Bockarie, et al.
Plos Neglected Tropical Diseases|May 19, 2023
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasisNicholas O Opoku, Felix Doe, Bettina Dubben, et al.
Plos Neglected Tropical Diseases|December 12, 2022
Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in AfricaWilma A Stolk, Luc E Coffeng, Fatorma K Bolay, et al.
Plos Genetics|January 7, 2017
Genomes of Fasciola hepatica from the Americas Reveal Colonization with Neorickettsia Endobacteria Related to the Agents of Potomac Horse and Human Sennetsu FeversSamantha N McNulty, Jose F Tort, Gabriel Rinaldi, et al.
Plos Neglected Tropical Diseases|January 9, 2016
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulusAllison Golden, Eric J Stevens, Lindsay Yokobe, et al.
Plos Neglected Tropical Diseases|March 9, 2019
Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in CameroonSamuel Wanji, Mathias Eyong Esum, Abdel Jelil Njouendou, et al.
Plos Medicine|June 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized studyGary J Weil, Joshua Bogus, Michael Christian, et al.
Plos Neglected Tropical Diseases|March 3, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasisAlison Krentel, Nandha Basker, Madsen Beau de Rochars, et al.
Plos Neglected Tropical Diseases|January 25, 2012
A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasisKatherine Gass, Madsen V E Beau de Rochars, Daniel Boakye, et al.
Plos Neglected Tropical Diseases|December 17, 2013
Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluationBrian K Chu, Michael Deming, Nana-Kwadwo Biritwum, et al.
Pageof 11